文献
J-GLOBAL ID:201802267678518775
整理番号:18A1804170
HER2陰性乳癌に対するネオアジュバント化学療法としての毎週のナノ粒子アルブミン結合パクリタキセル(150mg/m2)とそれに続くフルオロウラシル,エピルビシンおよびシクロホスファミド療法の実現可能性研究【JST・京大機械翻訳】
Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m2) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer
著者 (8件):
Kojima Yasuyuki
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
,
Kawamoto Hisanori
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
,
Nishikawa Toru
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
,
Hayami Ryosuke
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
,
Shimo Arata
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
,
Haku Ei
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
,
Akiyama Kyoko
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
,
Tsugawa Koichiro
(Division of Breast and Endocrine Surgery, Department of Surgery, St Marianna University School of Medicine, Miyamae, Japan)
資料名:
Clinical Breast Cancer
(Clinical Breast Cancer)
巻:
18
号:
5
ページ:
374-379
発行年:
2018年
JST資料番号:
W3206A
ISSN:
1526-8209
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)